Tessa M. Andermann

1.3k total citations
29 papers, 630 citations indexed

About

Tessa M. Andermann is a scholar working on Molecular Biology, Infectious Diseases and Oncology. According to data from OpenAlex, Tessa M. Andermann has authored 29 papers receiving a total of 630 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 11 papers in Infectious Diseases and 9 papers in Oncology. Recurrent topics in Tessa M. Andermann's work include Gut microbiota and health (14 papers), Clostridium difficile and Clostridium perfringens research (9 papers) and Helicobacter pylori-related gastroenterology studies (5 papers). Tessa M. Andermann is often cited by papers focused on Gut microbiota and health (14 papers), Clostridium difficile and Clostridium perfringens research (9 papers) and Helicobacter pylori-related gastroenterology studies (5 papers). Tessa M. Andermann collaborates with scholars based in United States and Malawi. Tessa M. Andermann's co-authors include Ami S. Bhatt, Karen M. Ottemann, Niaz Banaei, Fiona B. Tamburini, Andrew R. Rezvani, Tkachenko Ei, Fiona Senchyna, S. M. Williams, Lisa Sanders and Yu-Ting Chen and has published in prestigious journals such as Nature Medicine, Nature Communications and Blood.

In The Last Decade

Tessa M. Andermann

23 papers receiving 625 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tessa M. Andermann United States 12 318 156 137 87 86 29 630
Ryan W. Honaker United States 11 290 0.9× 204 1.3× 176 1.3× 83 1.0× 53 0.6× 15 627
Anne Vachée France 15 205 0.6× 189 1.2× 147 1.1× 55 0.6× 57 0.7× 44 656
Hengameh Chloé Mirsepasi‐Lauridsen Denmark 9 397 1.2× 155 1.0× 71 0.5× 54 0.6× 28 0.3× 11 606
Zelin Cui China 17 498 1.6× 194 1.2× 33 0.2× 105 1.2× 66 0.8× 33 940
Lynda Mottram Sweden 8 344 1.1× 330 2.1× 88 0.6× 162 1.9× 23 0.3× 12 699
Peechanika Chopjitt Thailand 13 173 0.5× 75 0.5× 96 0.7× 27 0.3× 131 1.5× 53 554
Gil Weitzman United States 3 352 1.1× 171 1.1× 101 0.7× 46 0.5× 29 0.3× 4 563
Genyan Liu China 16 321 1.0× 221 1.4× 49 0.4× 95 1.1× 234 2.7× 42 860
Chuan Chiang-Ni Taiwan 16 223 0.7× 318 2.0× 56 0.4× 56 0.6× 43 0.5× 47 823

Countries citing papers authored by Tessa M. Andermann

Since Specialization
Citations

This map shows the geographic impact of Tessa M. Andermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tessa M. Andermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tessa M. Andermann more than expected).

Fields of papers citing papers by Tessa M. Andermann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tessa M. Andermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tessa M. Andermann. The network helps show where Tessa M. Andermann may publish in the future.

Co-authorship network of co-authors of Tessa M. Andermann

This figure shows the co-authorship network connecting the top 25 collaborators of Tessa M. Andermann. A scholar is included among the top collaborators of Tessa M. Andermann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tessa M. Andermann. Tessa M. Andermann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Serody, Jonathan S., Paul M. Armistead, Gianpietro Dotti, et al.. (2025). Infectious Complications Following CD30 Chimeric Antigen Receptor T-cell Therapy in Adults. Open Forum Infectious Diseases. 12(9). ofaf541–ofaf541.
3.
Tompkins, Kathleen, Andreea Waltmann, Emily J. Ciccone, et al.. (2024). Impact of Sulfadoxine-Pyrimethamine and Dihydroartemisinin-Piperaquine as Intermittent Preventive Treatment in Pregnancy on Stool Antimicrobial Resistance Gene Abundance. American Journal of Tropical Medicine and Hygiene. 111(1). 43–47. 1 indexed citations
4.
Messina, Julia A., Jennifer L. Saullo, Tessa M. Andermann, et al.. (2023). 2708. Infectious Complications Among CD19 Chimeric Antigen Receptor T-cell Recipients. Open Forum Infectious Diseases. 10(Supplement_2). 1 indexed citations
5.
Palmer, Shannon, Dominic T. Moore, Luther A. Bartelt, et al.. (2023). Utility of Urine Cultures During Febrile Neutropenia Workup in Hematopoietic Stem Cell Transplantation Recipients Without Urinary Symptoms. Open Forum Infectious Diseases. 10(5). ofad236–ofad236. 5 indexed citations
6.
Messina, Julia A., Lauren Hill, Amy Bush, et al.. (2023). 294. The Impact of Mucositis on the Oral Microbiome and Clinical Outcomes in Allogenic Hematopoietic Stem Cell Transplantation. Open Forum Infectious Diseases. 10(Supplement_2).
8.
Andermann, Tessa M. & Aadra P. Bhatt. (2022). The mother of all synbiotics: Just a spoonful of sugar makes the bugs stick around. Cell Host & Microbe. 30(5). 601–603. 1 indexed citations
9.
Siranosian, Benjamin A., Erin F. Brooks, Tessa M. Andermann, et al.. (2022). Rare transmission of commensal and pathogenic bacteria in the gut microbiome of hospitalized adults. Nature Communications. 13(1). 586–586. 30 indexed citations
10.
Chang, Patricia P., et al.. (2021). Unexpected case of chagas disease reactivation in endomyocardial biopsy for evaluation of cardiac allograft rejection. Cardiovascular Pathology. 57. 107394–107394. 3 indexed citations
11.
Messina, Julia A., Yi Ren, Lauren Hill, et al.. (2021). Enterococcus Intestinal Domination Is Associated With Increased Mortality in the Acute Leukemia Chemotherapy Population. Clinical Infectious Diseases. 78(2). 414–422. 13 indexed citations
12.
Zlitni, Soumaya, Alex Bishara, Eli L. Moss, et al.. (2020). Strain-resolved microbiome sequencing reveals mobile elements that drive bacterial competition on a clinical timescale. Genome Medicine. 12(1). 50–50. 34 indexed citations
13.
Kang, Joyce B., Benjamin A. Siranosian, Eli L. Moss, et al.. (2019). Intestinal microbiota domination under extreme selective pressures characterized by metagenomic read cloud sequencing and assembly. BMC Bioinformatics. 20(S16). 585–585. 4 indexed citations
14.
Andermann, Tessa M., Fiona B. Tamburini, Tkachenko Ei, et al.. (2018). Diverse Bloodstream Pathogens Are Identified in the Gut Microbiome Prior to Infection in Hematopoietic Stem Cell Transplantation Recipients. Blood. 132(Supplement 1). 2091–2091. 1 indexed citations
15.
Senchyna, Fiona, Rajiv L. Gaur, Johanna Sandlund, et al.. (2018). Diversity of resistance mechanisms in carbapenem-resistant Enterobacteriaceae at a health care system in Northern California, from 2013 to 2016. Diagnostic Microbiology and Infectious Disease. 93(3). 250–257. 63 indexed citations
16.
Kang, Joyce B., Benjamin A. Siranosian, Eli L. Moss, Tessa M. Andermann, & Ami S. Bhatt. (2018). Read cloud sequencing elucidates microbiome dynamics in a hematopoietic cell transplant patient. PubMed. 2018. 234–241. 1 indexed citations
17.
Andermann, Tessa M., et al.. (2018). A Phase I Study of the Prebiotic Fructooligosaccharide in Allogeneic HCT and Evaluation of the Impact of This Compound on the Intestinal Microbiome. Biology of Blood and Marrow Transplantation. 24(3). S378–S379. 1 indexed citations
18.
19.
Andermann, Tessa M., Andrew R. Rezvani, & Ami S. Bhatt. (2016). Microbiota Manipulation With Prebiotics and Probiotics in Patients Undergoing Stem Cell Transplantation. Current Hematologic Malignancy Reports. 11(1). 19–28. 57 indexed citations
20.
Andermann, Tessa M., Yu-Ting Chen, & Karen M. Ottemann. (2002). Two Predicted Chemoreceptors of Helicobacter pylori Promote Stomach Infection. Infection and Immunity. 70(10). 5877–5881. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026